ArticleEBioMedicine2020

DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing.

Patrick J Engelberts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.